Skip to main content
. 2025 Jan 3;10(1):104089. doi: 10.1016/j.esmoop.2024.104089

Figure 4.

Figure 4

Overall survival of the per-protocol population of end-stage cancer patients according to groups with no druggable target present, druggable target present but untreated, and druggable target present and treated (P = 0.003). Index date is date of the National Molecular Tumor Board. Patients alive at the day of last follow-up are censored as indicated by +.